Several companies play pivotal roles in shaping the influenza tests market, offering a range of diagnostic solutions and contributing to advancements in testing technologies.

Buy the Full Report for More Segment Insights into the Influenza Tests Market

Download a Free Report Sample

Here are some key players in the influenza tests market:

1. Abbott Laboratories:

   • Abbott offers a broad portfolio of influenza diagnostic tests, including rapid influenza diagnostic tests (RIDTs) and molecular assays. The company's ID NOW™ platform provides rapid results for influenza A and B viruses within minutes.

2. Roche Diagnostics:

   • Roche Diagnostics develops and manufactures a variety of influenza testing solutions, including nucleic acid amplification tests (NAATs) and automated molecular assays. The cobas® Liat® system enables rapid detection of influenza viruses in point-of-care settings.

3. Quidel Corporation:

   • Quidel is a leading provider of rapid diagnostic testing solutions, including Sofia® and Sofia® 2 systems for influenza and respiratory syncytial virus (RSV) detection. The company's rapid antigen tests offer quick and reliable results for influenza diagnosis.

4. DiaSorin Molecular LLC:

   • DiaSorin Molecular specializes in molecular diagnostic solutions for infectious diseases, including influenza. The Simplexa™ Flu A/B & RSV Direct assay allows for the rapid detection and differentiation of influenza viruses and RSV.

5. Thermo Fisher Scientific:

   • Thermo Fisher Scientific offers a comprehensive range of influenza testing solutions, including real-time PCR assays, multiplex panels, and automated platforms such as the Applied Biosystems™ 7500 Fast Dx Real-Time PCR System.

6. Becton, Dickinson and Company (BD):

   • BD provides a variety of influenza testing products, including rapid antigen tests, molecular assays, and viral transport media. The BD Veritor™ Plus System offers rapid and reliable detection of influenza A and B viruses.

7. Cepheid (a subsidiary of Danaher Corporation):

   • Cepheid develops molecular diagnostic systems for a wide range of infectious diseases, including influenza. The Xpert® Xpress Flu/RSV assay delivers rapid and accurate results for influenza and respiratory syncytial virus (RSV) detection.

8. Bio-Rad Laboratories, Inc.:

   • Bio-Rad offers molecular diagnostic solutions for influenza detection, including the BioFire® Respiratory Panel 2.1. The panel provides comprehensive testing for multiple respiratory pathogens, including influenza A and B viruses.

9. Meridian Bioscience, Inc.:

   • Meridian Bioscience manufactures diagnostic tests for respiratory infections, including influenza. The illumigene® molecular assay platform offers rapid and sensitive detection of influenza viruses.

10. Abbexa Ltd:

    • Abbexa is a UK-based biotechnology company that offers a variety of influenza testing products, including antibodies, ELISA kits, and antigens for research and diagnostic applications.

These key players, along with other diagnostic companies and research institutions, contribute to the development, manufacturing, and distribution of influenza testing solutions worldwide. Their innovations and contributions play a crucial role in combating seasonal influenza outbreaks, monitoring disease prevalence, and supporting public health efforts.